| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Savara Inc | Director | Common Stock | 22.5K | $100K | $4.45 | Dec 14, 2023 | Direct |
| Savara Inc | Director | Stock Option (Right to Buy) | 40K | Dec 13, 2022 | Direct | ||
| PLUS THERAPEUTICS, INC. | Director | Stock Option (Right to Buy) | 3.65K | Sep 11, 2024 | Direct | ||
| LUMOS PHARMA, INC. | Director | Stock Option (Right to Buy) | 3.33K | Jun 5, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| PSTV | PLUS THERAPEUTICS, INC. | Sep 11, 2024 | 1 | $0 | 4 | Sep 12, 2024 | Director |
| (LUMO) | LUMOS PHARMA, INC. | Jun 5, 2024 | 1 | $0 | 4 | Jun 7, 2024 | Director |
| PSTV | PLUS THERAPEUTICS, INC. | Feb 22, 2024 | 1 | $0 | 4 | Feb 26, 2024 | Director |
| SVRA | Savara Inc | Dec 14, 2023 | 1 | $0 | 4 | Dec 15, 2023 | Director |
| LUMO | LUMOS PHARMA, INC. | May 10, 2023 | 1 | $0 | 4 | May 12, 2023 | Director |
| PSTV | PLUS THERAPEUTICS, INC. | Feb 15, 2023 | 1 | $0 | 4 | Feb 17, 2023 | Director |
| SVRA | Savara Inc | Dec 13, 2022 | 1 | $0 | 4 | Dec 15, 2022 | Director |
| LUMO | LUMOS PHARMA, INC. | May 5, 2022 | 1 | $0 | 4 | May 9, 2022 | Director |
| SVRA | Savara Inc | Dec 14, 2021 | 1 | $0 | 4 | Dec 14, 2021 | Director |
| PSTV | PLUS THERAPEUTICS, INC. | May 25, 2021 | 1 | $0 | 4 | May 27, 2021 | Director |
| LUMO | LUMOS PHARMA, INC. | May 20, 2021 | 2 | $0 | 4 | May 24, 2021 | Director |